The current CDNA market cap is 989.59M. The company's latest EPS is USD -3.6534 and P/E is -5.21.
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 77.26M | 70.3M | 67.19M | 65.57M | 72.05M |
Operating Income | -24.32M | -27.62M | -28.78M | -122.63M | -19.34M |
Net Income | -23.75M | -24.95M | -23.49M | -118.1M | -16.66M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 127.07M | 192.19M | 296.4M | 321.79M | 280.32M |
Operating Income | -24.53M | -22.53M | -29.73M | -77.23M | -203.36M |
Net Income | -21.97M | -18.71M | -30.66M | -76.61M | -190.28M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 528.22M | 514.82M | 501.18M | 466.83M | 452.41M |
Total Liabilities | 108.2M | 109.61M | 107.05M | 205.5M | 196.18M |
Total Equity | 420.02M | 405.21M | 394.13M | 261.33M | 256.23M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 151.74M | 368.51M | 566.62M | 542.99M | 466.83M |
Total Liabilities | 52.74M | 90.83M | 100.75M | 112.08M | 205.5M |
Total Equity | 99M | 277.68M | 465.88M | 430.91M | 261.33M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 671k | 172k | -10.01M | -18.39M | -15.31M |
Investing | -14.77M | 577k | -921k | 40.45M | 27.66M |
Financing | -1.14M | -2.7M | -2.73M | -29.61M | -1.28M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -2.77M | 33.43M | -19.29M | -25.24M | -18.39M |
Investing | -22.58M | -100.39M | 47.71M | -228.5M | 40.45M |
Financing | -132k | 163.15M | 185.64M | -4.54M | -29.61M |
Market Cap | 989.59M |
Price to Earnings Ratio | -5.21 |
Price to Sales Ratio | 3.54 |
Price to Cash Ratio | 12.06 |
Price to Book Ratio | 3.79 |
Dividend Yield | - |
Shares Outstanding | 52.08M |
Average Volume (1 week) | 686.28k |
Average Volume (1 Month) | 548.77k |
52 Week Change | 78.57% |
52 Week High | 19.58 |
52 Week Low | 4.80 |
Spread (Intraday) | 1.54 (7.86%) |
Company Name | CareDx Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.caredx.com |
Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.